Onco-Innovations Launches AI Oncology Research Collaboration

Onco-Innovations Limited announced the start of a research collaboration under the PROmAI programme. The partnership, involving its wholly‑owned subsidiary Inka Health Corp., aims to predict oncology outcomes using multimodal artificial intelligence. The announcement was made on 12 May 2026 in Vancouver, Canada. Onco‑Innovations trades on the CBOE Canada, OTCQB and Frankfurt Stock Exchanges under the symbols ONCO, ONNVF and W1H respectively.